Medical/Pharmaceuticals
Argon Medical Announces the Commercial Launch of Two Inferior Vena Cava Filter Retrieval Kits
FRISCO, Texas, Jan. 22, 2020 /PRNewswire/ -- Argon Medical Devices, Inc. announced today the commercial launch of Single-Loop and Triple-Loop Retrieval Kits for sale in the U.S. The Single-Loop and Triple-Loop Retrieval Kits are intended for percutaneous removal of retrievable inferior vena cava ...
Eddy Cojulun New Chief Sales Officer at Envirotainer
UPPLANDS VASBY, Sweden, Jan. 22, 2020 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced thatEddy Cojulun joined Envirotainer as the new Chief Sales Officer (CSO) inDecember 2019. In his new role Eddy will r...
LABWorld China 2020 is Gearing Up
SHANGHAI, Jan. 22, 2020 /PRNewswire/ -- The National Medical Products Administration (NMPA) announced the first 45 key laboratories inJune 2019 and mentioned that the construction of national-level innovative key laboratories would play a guiding and demonstrated role in improving drug sci-tech ...
Medical Director of Amaris B. Clinic Dr Ivan Puah Predicts 2020 Cosmetic Surgery Trend
SINGAPORE, Jan. 22, 2020 /PRNewswire/ -- Dr Ivan Puah, Medical Director of Amaris B. Clinic, who is accredited by the Ministry ofSingapore to perform surgical body sculpting treatments, has seen a plethora of diverse concerns from 25- to 65-year-old male and female patients inSingapore. 1. ...
Cognate BioServices closes Series B and completes acquisition of Cobra Biologics
MEMPHIS, Tennessee, Jan. 21, 2020 /PRNewswire/ -- Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of Cobra Biologics, a leading CDMO speciali...
US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma
* Biologics License Application based on results from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) in heavily pre-treated patient population who was refractory to an immunomodulatory drug and a proteasome inhibitor, and refractory or intolerant to an ...
3B Scientific Acquires iSimulate
HAMBURG, Germany, Jan. 21, 2020 /PRNewswire/ -- Today, 3B Scientific, a portfolio company of J.H. Whitney Capital Partners, LLC and the world's leading manufacturer and marketer of anatomical models and medical simulation products for healthcare and patient education, announced that it has entere...
Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team
HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- The leading transcatheter heart valve medical device player inChina - Venus Medtech (Hangzhou) Inc. ("Venus Medtech" or the "Company", stock code: 2500.HK), today is pleased to announce the appointment of two new cardiovascular experts to its advisor...
Mindray Launches New TE7 ACE Point-of-Care Solution to Improve Diagnostic Confidence
SHENZHEN, China, Jan. 20, 2020 /PRNewswire/ -- Mindray Medical (SZSE: 300760),
a leading global provider of medical devices and solutions, announces the
release of its new Point-of-Care Ultrasound System,TE7 ACE
China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMPK Activator Program
STOCKHOLM, Jan. 20, 2020 /PRNewswire/ -- Balticgruppen Bio, the Umea based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has closed a funding round withChina based asset management firm Ivy Capital granting the company 3 MUSD of fundi...
QBiotics receives first registration for tigilanol tiglate with European Medicines Agency approval of Stelfonta(R)
* STELFONTA® (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment available for all grades of canine non-metastatic mast cell tumours (MCT)[1] * The approval marks the first registration of QBiotic's, lead compound tigilanol tiglate...
LimaCorporate Inaugurates the New Research & Innovation Center for 3D Printing and the Advanced Laboratory for Testing and Analysis (ATLAs)
UDINE, Italy, Jan. 16, 2020 /PRNewswire/ -- LimaCorporate announces the official opening of new spaces entirely dedicated to 3D Printing and advanced testing: the Research & Innovation Center (R&I Center) and the Advanced Laboratory for Testing and Analysis (ATLAs). These new areas are located in...
FDF China to be held in June to boost Chinese pharmaceutical enterprises to "go global" and promote the innovation and development of industry
SHANGHAI, Jan. 16, 2020 /PRNewswire/ -- FDF China, collocated with CPhI China, will be held fromJune 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the inte...
Europ Assistance opens new office in Thailand
BANGKOK, Jan. 15, 2020 /PRNewswire/ -- Europ Assistance today announced the opening of their new office inBangkok, Thailand to provide its world-renowned travel and medical networks to the region and complete the presence of the Generali Group inThailand. This is part of their overall plan to acc...
ZAP Surgical Brain Tumor Treatments Commence at PLA General Hospital 301 in Beijing, China
SAN CARLOS, California, Jan. 14, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc. today announced that its ZAP-X® Gyroscopic Radiosurgery™ platform began clinical stereotactic radiosurgery (SRS) treatments at PLA General Hospital 301 (PLAGH 301) inBeijing, China. PLAGH 301 is the largest hospital ...
Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada
SUZHOU, China, Jan. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced tha...
Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer
SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt,Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical ...
Evolution 2.0 Prize: Unprecedented $10 Million Offered To Replicate Cellular Evolution
CHICAGO, Jan. 14, 2020 /PRNewswire/ -- An incentive prize ten times the size of the Nobel – believed to be the largest single award ever in basic science – is being offered to the person or team solving the largest mystery in history: how genetic code inside cells got there, and how cells intent...
Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020
CHICAGO, Jan. 14, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, will be showcasing the first of-its-kind flexible Coronary Essentials training solution at the 20th International Meeting on Simulation in Healthcare (IMSH 2020) inSan...
EW Nutrition Launches Revolutionary Enzyme in India
HYDERABAD, India, Jan. 13, 2020 /PRNewswire/ -- In December 2019, EW Nutrition has officially launched Axxess XY, a novel, intrinsically thermostable xylanase enzyme that delivers top performance to feed producers and the livestock industry. The revolutionary product was launched at a customer-ce...
Week's Top Stories
Most Reposted
Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 305 media titles]
2024-11-20 13:29Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 304 media titles]
2024-11-21 10:30Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 300 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25